Transition of ADHD Patients from Childhood into Adulthood
Volume 4 Issue 2, pages 44-51
Published December 2018
Dr Allison Kirsop
Rosswrite Medical Writing, Gorebridge, Midlothian, UK.
Corresponding Author: Allison Kirsop – email@example.com
This article summarises the current knowledge base and cutting-edge research into ADHD as presented at the
Medice symposium, 5th EUNETHYDIS International Conference on ADHD, 25 September 2018, Edinburgh, UK. The
clinical perspective presents an overview of how ADHD symptoms change over an individual’s lifespan, the effects of comorbidity, and current treatment options. There is a high genetic correlation of ADHD with psychiatric disorders such as depression, signifying that ADHD is biologically determined and genetically driven. The neurobiological aspect provides insight into the genetic contribution to ADHD and the success of collaborative initiatives which serve to increase understanding into the genes and biological pathways involved.
Key words: ADHD; transition; clinical; lifespan; neurobiological; imaging
Acknowledgements: We thank the following faculty for their valuable contributions to the symposium:
Professor Andreas Reif, Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt – Goethe University, Frankfurt am Main, Germany.
Professor Tobias Banaschewski, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
Professor Barbara Franke, Radbound University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Nijmegen, The Netherlands.
Acknowledgement of thanks is also extended to Oruen Ltd., for editorial assistance in the preparation of this article.